The life sciences field is defined by numerous features: strong growth, constant innovation, long-term cycles of development, increasing international competition and complex financing. All of them require personalized and adapted solutions.

Dentons’ Life Sciences group in Europe makes it a priority to understand the scientific and economic tools and data necessary to provide effective legal guidance on complex health care issues. We advise you on the complete range of services and considerations, including:

• M&A
• Corporate and commercial law
• Regulatory law
• Distribution
• Intellectual property and patent advice
• Competition
• Tax
• Employment law
• Dispute resolution and arbitration

Whether your business is a public or private player, a medical or biological institution, a manufacturer, distributor or service provider in the health care sector, you faces a wide array of challenges in this multifaceted field. When confronting products commercialization, service delivery or capitalization on scientific breakthrough, it is crucial for your business to find relevant and solid legal advice to optimize the return on your investments and achieve your business goals.

Our teams offer tailored assistance and in-depth knowledge of health care products and activities, providing quick responses to urgent situations. We can also structure complex licensing, distribution, co-promotion, development and manufacturing agreements to help you keep projects moving, while mitigating risks.

Recognition

Dentons named Financial & Corporate Firm of the Year: Corporate at the 2020 LMG European Life Sciences Awards

June 11, 2020

We are pleased to announce that the 2020 LMG European Life Sciences recognized Dentons as the winner in the Financial & Corporate Firm of the Year: Corporate category.

Dentons Europe ranked among the top Life Sciences law firms

June 10, 2015

Dentons Europe has been ranked among the top Life sciences law firms in Chambers Europe 2015, Legal 500 2015 and Décideurs - Stratégie Finance Droit  2015.

Dentons Europe ranked among the top Life Sciences law firms

September 27, 2013

Dentons Europe has been ranked among the top Life sciences law firms in Chambers Europe 2013, Legal 500 2013 and Décideurs - Stratégie Finance Droit 2013.

View all recognition for Life Sciences in Europe

Insights

Life Sciences Legal Update - Q1 2024

March 27, 2024

Czech Republic: We bring you the first 2024 edition of the quarterly Life Science Legal Update, in which we regularly cover key legal aspects and innovations in the Pharmaceuticals and Life Sciences sectors. The first quarter of 2024 is full of news in the pharmaceutical, healthcare services and food sectors. For instance, there has been much discussion about limiting the availability of HHC substances to consumers; in addition, several implementing regulations for the amendment to the Medicines Act have come into force as well as a new pricing regulation under which health insurers will now be able to request a maximum price for a specific medicinal product as part of an exceptional reimbursement regime. The EU is about to negotiate the draft pharmaceutical package presented by the European Commission. Last but not least, the major amendment to the Significant Market Power Act which has been newly effected, and which largely affects buyer-supplier relationships in the supply of food, agricultural products and other related services.

Life Sciences Legal Update - Q1 2024 (Czech)

March 27, 2024

Czech Republic: We bring you the first 2024 edition of the quarterly Life Science Legal Update, in which we regularly cover key legal aspects and innovations in the Pharmaceuticals and Life Sciences sectors. The first quarter of 2024 is full of news in the pharmaceutical, healthcare services and food sectors. For instance, there has been much discussion about limiting the availability of HHC substances to consumers; in addition, several implementing regulations for the amendment to the Medicines Act have come into force as well as a new pricing regulation under which health insurers will now be able to request a maximum price for a specific medicinal product as part of an exceptional reimbursement regime. The EU is about to negotiate the draft pharmaceutical package presented by the European Commission. Last but not least, the major amendment to the Significant Market Power Act which has been newly effected, and which largely affects buyer-supplier relationships in the supply of food, agricultural products and other related services.

Dentons Prague Alert - Amendment to the Medicines Act

January 11, 2024

Czech Republic: On 29 December, the Amendment to the Medicines Act was published in the Collection of Laws, in volume 203 under number 456/2023 Coll. Barring one exception, the amendment already went into effect on 1 January 2024.

View all insights for Life Sciences in Europe

News and Events

Recent Press Releases

Dentons advises Septodont on the acquisition of Spanish Laboratorios Inibsa

November 21, 2024

Septodont, a leading manufacturer of dental products, and Acteon, a leading manufacturer of dental products and medical devices, finalized the acquisition of Laboratorios Inibsa, a global pharmaceutical group located in Barcelona (Spain) specializing in the development and manufacturing of products for dental practitioners and dental professionals. 

Dentons recruits M&A Partner Inmaculada Castelló in Spain

May 7, 2024

Global law firm Dentons has recruited Inmaculada Castelló to join as a Partner in the Corporate and M&A practice in Madrid.

Dentons and EURORDIS form pro bono alliance

January 10, 2024

Global law firm Dentons has concluded an agreement to provide EURORDIS-Rare Diseases Europe with pro bono legal services.

View all press releases for Life Sciences in Europe